Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02921698
Other study ID # SAFE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2014
Est. completion date December 2017

Study information

Verified date August 2017
Source Microvention-Terumo, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Patient is aged =18 years

2. Patient has an unruptured or recanalized intracranial aneurysm :

- for which an endovascular treatment has been determined appropriate

- that can not be treated by standard techniques (coiling with or without remodeling)

- and for which the FRED® Flow Diverter has been determined an appropriate treatment

3. Patient or patient's legally authorized representative has been informed about the confidentiality of the study and agrees to the collection of his/her personal data

4. Patient presents with an mRS score between 0 and 2

5. Patients who have already been treated with a stent or a flow diverter for another aneurysm may be included if:

- the previous treatment was more than three months prior to enrollment in this study

- the aneurysm to be treated for this study is a new aneurysm located on a different parent vessel unless the stent already in place is implanted on the proximal carotid artery.

Exclusion Criteria:

1. Patient has a known allergy to antiplatelet therapy, heparin and/or contrast medium

2. Patient has contraindication to antiplatelet therapy and/or heparin

3. Patient is pregnant and/or breastfeeding

4. Patient may not benefit from imaging and clinical monitoring

5. Patient has a medical or surgical co-morbidities limiting his/her life expectancy to less than 1 year

6. Patient will be treated with a flow diverter other than FRED®

7. Patient had an intracranial hemorrhage within the 30 days preceding treatment

8. Patient has an aneurysm(s) with one or more of the following characteristics:

- associated with an arteriovenous malformation

- dissecting or ""blister-like""

- multiple (unless only one aneurysm requires treatment)

- located in the posterior circulation

- treated with a stent or a flow diverter on the same parent vessel (excluding proximal carotid artery) or in the 3 months prior to inclusion

9. Patient has stenosis of the aneurysm parent artery.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
FRED®
Flow Re-Direction Endoluminal Device

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Microvention-Terumo, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Aneurysm occlusion without ? 50% parent artery stenosis 6 months
Primary Morbidity rate 6 months
Primary Mortality rate 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02879175 - Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms
Completed NCT01139892 - The Canadian UnRuptured Endovascular Versus Surgery Trial (CURES)
Recruiting NCT06411418 - Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm N/A
Completed NCT02312856 - Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction N/A
Recruiting NCT01054391 - Neurovascular Embolization Cover for Treatment of Intracranial Aneurysms and Carotid/Vertebrobasilar Fistulae N/A
Completed NCT02657772 - Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms
Completed NCT01465841 - Study of the Penumbra Coil 400 System to Treat Aneurysm N/A
Enrolling by invitation NCT05453240 - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the LVIS Device
Completed NCT03550638 - Coil System(Ton-bridgeMT) for Endovascular Embolization of Cranial Aneurysms N/A
Terminated NCT02122133 - CARE: A Prospective Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400
Completed NCT01541254 - Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device Phase 2/Phase 3
Terminated NCT01320306 - Intracranial Aneurysms and Cognitive Function
Recruiting NCT01084681 - Efficacy Trial of Intracranial Aneurysm Treatment Using Two Different Endovascular Techniques N/A
Completed NCT00396981 - MAPS Trial: Matrix And Platinum Science Phase 4
Completed NCT02921711 - TRAIL: Treatment of Intracranial Aneurysms With LVIS® System
Recruiting NCT01031147 - Contrast-free Magnetic Resonance Angiography (MRA) at 3.0 T for Intracranial Aneurysm Detection N/A
Recruiting NCT05636124 - Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms N/A
Terminated NCT01974700 - Seizure Prophylaxis in Aneurysm Repair Phase 4
Completed NCT01801007 - Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms N/A
Completed NCT01793792 - Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support) N/A